Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 Trial of Plazomicin vs Meropenem for Complicated Urinary Tract Infection
2015-001588-37Phase 3Completed
- Sponsor
- Achaogen, Inc.
- Start
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of plazomicin in complicated urinary tract infection (cUTI), acute pyelonephritis and urinary tract infection (UTI) (2 arms), sponsored by Achaogen, Inc. Primary endpoint: Composite microbiological eradication and clinical cure rate at Day 5 and test-of-cure (TOC). Started Jun 2015; status: completed.
02
Drugs
plazomicin
03
Conditions
complicated urinary tract infection (cUTI)acute pyelonephritisurinary tract infection (UTI)
Beyond the preview
Go deeper on 2015-001588-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-001588-37.